Canadian Rhinology Working Group consensus statement: biologic therapies for chronic rhinosinusitis

BACKGROUND: Recent evidence suggests that biologic therapy with targeted activity within the Type 2 inflammatory pathway can improve the clinical signs and symptoms of chronic rhinosinusitis with nasal polyposis (CRSwNP). There remains a population in CRSwNP that despite medical therapy and endoscop...

Descripción completa

Detalles Bibliográficos
Autores principales: Thamboo, Andrew, Kilty, S., Witterick, I., Chan, Y., Chin, C. J., Janjua, A., Javer, A., Lee, J., Monterio, E., Rotenberg, B., Scott, J., Smith, K., Sommer, D. D., Sowerby, L., Tewfik, M., Wright, E., Desrosiers, M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7945300/
https://www.ncbi.nlm.nih.gov/pubmed/33750471
http://dx.doi.org/10.1186/s40463-021-00493-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7945300/
https://www.ncbi.nlm.nih.gov/pubmed/33750471
http://dx.doi.org/10.1186/s40463-021-00493-2

Ejemplares similares